Linda Skaling Therkorn

Array ( [id] => 4096600 [patent_doc_number] => 06066323 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-23 [patent_title] => 'Use of antibodies to sialidase as anti-infectious agents and anti-inflammatory agents' [patent_app_type] => 1 [patent_app_number] => 8/736236 [patent_app_country] => US [patent_app_date] => 1996-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3630 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/066/06066323.pdf [firstpage_image] =>[orig_patent_app_number] => 736236 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4041523 [patent_doc_number] => 05869047 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-09 [patent_title] => 'Methods for therapeutically treating immunocomprised persons' [patent_app_type] => 1 [patent_app_number] => 8/734941 [patent_app_country] => US [patent_app_date] => 1996-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6962 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/869/05869047.pdf [firstpage_image] =>[orig_patent_app_number] => 734941 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3831952 [patent_doc_number] => 05739306 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-14 [patent_title] => 'gC1q receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodies' [patent_app_type] => 1 [patent_app_number] => 8/711175 [patent_app_country] => US [patent_app_date] => 1996-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 11611 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/739/05739306.pdf [firstpage_image] =>[orig_patent_app_number] => 711175 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3730589 [patent_doc_number] => 05652333 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-29 [patent_title] => 'gC1q receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodies' [patent_app_type] => 1 [patent_app_number] => 8/709047 [patent_app_country] => US [patent_app_date] => 1996-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 11600 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/652/05652333.pdf [firstpage_image] =>[orig_patent_app_number] => 709047 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3827394 [patent_doc_number] => 05731428 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-24 [patent_title] => 'gC1q receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodies' [patent_app_type] => 1 [patent_app_number] => 8/709006 [patent_app_country] => US [patent_app_date] => 1996-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 11594 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/731/05731428.pdf [firstpage_image] =>[orig_patent_app_number] => 709006 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3837359 [patent_doc_number] => 05707626 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-13 [patent_title] => 'Methods of treating HIV infection using antibodies to the U2 small nuclear ribonuclear protein' [patent_app_type] => 1 [patent_app_number] => 8/704170 [patent_app_country] => US [patent_app_date] => 1996-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 17864 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/707/05707626.pdf [firstpage_image] =>[orig_patent_app_number] => 704170 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4051805 [patent_doc_number] => 05932550 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-03 [patent_title] => 'Dipeptide compound or pharmaceutically acceptable salt thereof and medical use thereof' [patent_app_type] => 1 [patent_app_number] => 8/669757 [patent_app_country] => US [patent_app_date] => 1996-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15939 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/932/05932550.pdf [firstpage_image] =>[orig_patent_app_number] => 669757 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3786947 [patent_doc_number] => 05780033 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-14 [patent_title] => 'Use of autoantibodies for tumor therapy and prophylaxis' [patent_app_type] => 1 [patent_app_number] => 8/563901 [patent_app_country] => US [patent_app_date] => 1995-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 6671 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/780/05780033.pdf [firstpage_image] =>[orig_patent_app_number] => 563901 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3764691 [patent_doc_number] => 05852186 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-22 [patent_title] => 'Reactive neutralizing human anti-GP120 recombinant antibody, DNA coding the same and use thereof' [patent_app_type] => 1 [patent_app_number] => 8/480774 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 22 [patent_no_of_words] => 20386 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/852/05852186.pdf [firstpage_image] =>[orig_patent_app_number] => 480774 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3831936 [patent_doc_number] => 05814519 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-29 [patent_title] => 'Supressor of HIV-1 replication and transcription' [patent_app_type] => 1 [patent_app_number] => 8/488527 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 20 [patent_no_of_words] => 11835 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/814/05814519.pdf [firstpage_image] =>[orig_patent_app_number] => 488527 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3937581 [patent_doc_number] => 05976544 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-02 [patent_title] => 'Polypeptides and vaccines for Bordetellapertussis and method of use' [patent_app_type] => 1 [patent_app_number] => 8/474386 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 7091 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/976/05976544.pdf [firstpage_image] =>[orig_patent_app_number] => 474386 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4092075 [patent_doc_number] => 06133424 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-17 [patent_title] => 'ppRB.sup.110 - nuclear phosphoprotein-the retinoblastoma susceptibility gene product' [patent_app_type] => 1 [patent_app_number] => 8/485042 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 13 [patent_no_of_words] => 9939 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/133/06133424.pdf [firstpage_image] =>[orig_patent_app_number] => 485042 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3828478 [patent_doc_number] => 05783670 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-21 [patent_title] => 'Monoclonal antibodies specific for HIV and the hybridomas for production thereof' [patent_app_type] => 1 [patent_app_number] => 8/487529 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 22 [patent_no_of_words] => 12378 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/783/05783670.pdf [firstpage_image] =>[orig_patent_app_number] => 487529 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3615318 [patent_doc_number] => 05534621 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-07-09 [patent_title] => 'Immunoaffinity purification methods using single polypeptide chain binding molecules' [patent_app_type] => 1 [patent_app_number] => 8/468992 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 55 [patent_figures_cnt] => 72 [patent_no_of_words] => 23532 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/534/05534621.pdf [firstpage_image] =>[orig_patent_app_number] => 468992 [rel_patent_id] =>[rel_patent_doc_number] =>)